Produce a one-page buying brief and a small, usable evidence pack. The immediate objective is to identify the decision you can actually make.
Scope checklist
- Name the executive sponsor, procurement owner, clinical approver, legal reviewer and implementation lead.
- Record the decision deadline, renewal notice date and any existing commitments.
- Classify the arrangement: clinic stock, patient dispensing, facilitated access, or a combination.
- Identify who selects the pharmacy, who owns the medicine, who pays each charge and who holds each contract.
- List current and planned destination states, products, presentations and clinically supplied dose-mix assumptions.
- Separate clinic-controlled spending from patient expenditure and insurer payments.
- Identify the immediate objective: continuity, affordability, reduced administrative work, expansion or consolidation.
Evidence-pack checklist
Request existing contracts and amendments, redacted quotations and invoices, supplier legal names and facility addresses, aggregate prescription volumes, delivery exceptions, refunds, support workload and integration documentation.
For this diagnostic, use business-level and aggregate information. Keep patient identifiers, prescription images and clinical records out of the research intake. Any subsequent patient-data workflow should receive its own privacy and security review; HHS distinguishes business-associate services from provider-to-provider disclosures for treatment. (hhs.gov)
Exit test: finance can explain which costs the clinic controls, operations can name the workflow being changed, and clinical leadership understands the affected patient groups. If not, defer the supplier competition and finish the scope.
Sources cited on this page
- hhs.gov · Source 1 ↗https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/business-associates/index.html